Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
Ekaterina V. KurbatovaU.S. Centers for Disease Control and Prevention, International Research and Programs Branch, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA. [email protected]A. TaylorU.S. Centers for Disease Control and Prevention, Atlanta, GA, USAVictoria M. GamminoU.S. Centers for Disease Control and Prevention, Atlanta, GA, USAJaime BayonaHarvard Medical School, Boston, MA, USAMercedes C. BecerraHarvard Medical School, Boston, MA, USAManfred DanilovitzTartu University Lung Hospital, Tartu, EstoniaDennis FalzonWorld Health Organization, Geneva, SwitzerlandIrina GelmanovaPartners In Health (Lima, Peru; Tomsk, Russia; Boston, MA, USA)Salmaan KeshavjeeHarvard Medical School, Boston, MA, USAVaira LeimaneRiga East Clinical University Hospital Clinic “Centre of Tuberculosis and Lung Diseases” Riga, LatviaCarole D. MitnickHarvard Medical School, Boston, MA, USAM. I. D. QuelapioTropical Disease Foundation, Manila, PhilippinesVija RiekstiņaRiga East Clinical University Hospital Clinic “Centre of Tuberculosis and Lung Diseases” Riga, LatviaPiret ViikleppNational Institute for Health Development, Tallinn, EstoniaMatteo ZignolWorld Health Organization, Geneva, SwitzerlandJ. Peter CegielskiU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
2012en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba